Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Superior vena cava obstruction

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Stridor, laryngeal oedema, severe respiratory distress, confusion, reduced consciousness, syncope/hypotension or rapidly progressive swelling indicates life-threatening SVC obstruction. Sit the patient upright, give oxygen if hypoxaemic, summon senior airway/critical-care help and contact acute oncology plus interventional radiology immediately; imaging must not delay stabilisation.

Synopsis

Recognise dangerous upper-body venous congestion, define tumour and thrombus rapidly and coordinate airway, stenting, cancer treatment and device-associated thrombosis care.

  • SVC obstruction is usually caused by intrathoracic malignancy, but central venous catheters, pacemaker/ICD leads and other devices increasingly cause or contribute to central thrombosis.
  • Facial/neck and bilateral arm swelling, venous plethora and dilated chest-wall collaterals that worsen lying flat or bending forward are classic.
  • Stridor, confusion, reduced consciousness, syncope or haemodynamic compromise marks severe obstruction and requires immediate multidisciplinary escalation.
  • Contrast-enhanced venous-phase CT of the thorax is the investigation of choice; extend to abdomen/pelvis for cancer staging and add a pulmonary angiographic phase when PE is suspected.
  • In a stable patient with suspected malignancy, obtain tissue diagnosis with oncology/respiratory planning before definitive chemotherapy or radiotherapy whenever feasible.
  • Endovascular stenting can relieve severe malignant obstruction quickly and does not prevent later biopsy, chemotherapy or radiotherapy.
  • For catheter-associated thrombosis, therapeutic anticoagulation is generally required for at least 3 months; a needed, functioning catheter can often remain if symptoms improve.
  • Remove a device when it is no longer needed, non-functional or infected, anticoagulation is impossible, symptoms fail to improve, or thrombosis is limb- or life-threatening.

Key red flags

Airway compromise

Stridor, laryngeal oedema, inability to lie flat, severe work of breathing or rapidly increasing neck swelling requires immediate airway/critical-care and interventional discussion.

Cerebral or circulatory compromise

Severe headache, visual disturbance, confusion, reduced consciousness, syncope, hypotension or renal hypoperfusion suggests critical venous obstruction.

Investigation priorities

01
Contrast-enhanced venous-phase CT thoraxFirst step

Confirm the site/severity of obstruction and distinguish external compression, tumour invasion and intraluminal thrombus.

Management branches

criticalAirway, neurological or circulatory compromise

Stridor/laryngeal oedema, severe distress, confusion/reduced consciousness, syncope/hypotension or rapidly progressive obstruction.

  1. First: sit upright, monitor continuously, give oxygen if hypoxaemic and summon senior anaesthetic/critical-care support; avoid sedation and unnecessary upper-limb cannulation where feasible.
  2. Next: contact acute oncology/respiratory and interventional radiology immediately; obtain contrast CT only when the airway and circulation are sufficiently stable.
  3. Next: prioritise urgent endovascular stenting for rapid decompression when anatomically feasible; anticoagulate if acute thrombus is present and bleeding risk permits.
  4. Escalation: if stenting is unavailable or unsuitable, the responsible oncology team directs urgent tumour-sensitive treatment while critical care manages airway/cerebral complications.
malignantStable suspected malignant obstruction

Clinical SVC obstruction without immediate airway, cerebral or circulatory compromise.

  1. First: discuss the same day with acute oncology/respiratory and obtain venous-phase contrast CT thorax, extending for staging as appropriate.

Key medicines

Dexamethasone8 mg orally twice daily, in the morning and at lunchtime; use IV administration at the same dose when swallowing is unsafe or impossible.Discuss urgently with oncology/haematology, particularly before biopsy when lymphoma is possible because steroids can obscure histology. Monitor glucose, infection, mental state and GI risk; taper as symptoms improve and review stopping if no response after about 7 days.
Omeprazole20 mg orally once daily while high-dose dexamethasone is used when gastroprotection is indicated.Review need when steroids stop; consider interactions and alternative lansoprazole 30 mg once daily where appropriate.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS Greater Glasgow and Clyde: Initial management of superior vena cava obstructionEmergency recognition, CT, biopsy planning, dexamethasone and specialist escalation.
  • ESVS 2021 clinical practice guidelines on venous thrombosisCatheter-related upper-extremity DVT anticoagulation duration and removal criteria.
  • ESMO clinical practice guideline: Venous thromboembolism in cancerCancer-associated thrombosis treatment selection and modifiers.
  • CIRSE quality assurance guidelines for SVC stenting in malignant diseaseIndications, rapid symptom relief and endovascular planning.
  • NICE NG158: Venous thromboembolic diseasesUK anticoagulant selection, cancer modifiers and treatment safety principles.
  • eMC: Clexane SmPCTherapeutic enoxaparin dosing, severe renal impairment and contraindications.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·

Next: plan the safest rapid tissue diagnosis before chemotherapy or radiotherapy whenever feasible; involve haematology early if lymphoma is possible because corticosteroids can reduce biopsy yield.
  • Next: for substantial symptoms, discuss stenting for prompt relief and consider dexamethasone 8 mg twice daily with the oncology team while diagnosis/treatment is organised.
  • Escalation: use histology and staging to select chemotherapy, radiotherapy or combined treatment; escalate immediately if stridor, neurological change or haemodynamic compromise develops.
    • Content changes
    Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom